中文EN

An innovative MedTech company

Our core focus lies in seamlessly integrating energy-based technologies with interventional techniques. Our company is dedicated to delivering disruptive technologies that effectively address the unmet clinical needs pertaining to cardiovascular diseases.

Our Vision

To become a medtech innovator with a global perspective

  • Our Research and Development Centre

    Shanghai: 21,528 sq. ft. of GMP production facility, 5,382 sq. ft. of R&D lab space, ISO 7 cleanroom for product development and manufacturing at scale.

    Singapore: R&D center specializing in the early-stage prototyping and design of innovative concepts. Our primary objective is to provide valuable expertise and allocate necessary resources to facilitate the development of state-of-the-art medical technologies.

  • Our Technology

    Our organization has developed a disruptive technological platform designed to address diverse clinical needs, primarily focused on mitigating challenges associated with cardiovascular calcification. This cutting-edge technology has been successfully employed in the treatment of stenotic lesions present in the lower limb arteries as well as coronary arteries. Additionally, we have filed multiple patent applications to protect the intellectual property related to the technology.

  • Our Team

    Our core team is composed of highly skilled professionals from diverse disciplines, including electrical engineering, mechanical engineering, acoustics engineering, biomedical engineering, and biomaterials engineering. This multidisciplinary approach allows us to leverage on a broad spectrum of expertise in our pursuit of innovation. Moreover, our extensive collaborations with esteemed medical experts worldwide further strengthen our ability to develop groundbreaking solutions.

TECHNOLOGYSPECTRUMEICS

Sonico Intravascular Lithotripsy (IVL) System

Spectrumedics Sonico IVL system employs a specialized shockwave catheter to precisely deliver acoustic pressure waves to calcified lesions present in both coronary and peripheral arteries. This innovative approach ensures the safe and controlled modification of calcium plaques within the arteries. Our technology offers a 360-degree circumferential energy discharge for the treatment of calcium, surpassing the conventional methods that utilize only 180 degrees of bidirectional energy discharge. This approach not only simplifies the treatment process but also enhances safety and effectiveness compared to traditional approaches.

Our technology offers a 360-degree circumferential energy discharge for the treatment of calcium, surpassing the conventional methods that utilize only 180 degrees of bidirectional energy discharge. This approach not only simplifies the treatment process but also enhances safety and effectiveness compared to traditional approaches.

Learn more

NEWS & EVENTSSPECTRUMEICS